Navigation Links
Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy
Date:12/18/2007

Richard P. Jones II named Vice President and General Manager of facility

that will dispense up to one million prescriptions a week

FRANKLIN LAKES, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS), one of the nation's leading pharmacy benefit managers, today announced that AllPoints at Anson in Whitestown, Indiana, will be the home of world's largest and most-advanced automated pharmacy, capping a nearly year-long search that spanned 48 states.

Medco selected Anson after narrowing its selections in early November to three different counties in central Indiana, where 1,300 new jobs will be created.

"We found all of the potential locations attractive for the facility. However, Anson stood out because of the attractive proposal and feature-rich site provided by developers Browning Investments and Duke Realty. There is a nice parallel between the Medco Therapeutic Resource Centers(TM) and the Anson planned community concept to create a new center of commercial, residential and civic activity in the region," said Medco President and Chief Operating Officer Kenny Klepper. "Anson will now be home to the pharmacy of the future -- a facility that uses the best of automation to safely dispense medications."

Medco also announced today that Richard P. Jones II will be vice president and general manager (VPGM) of the planned $140 million pharmacy, which takes up an area equal to six and a half football fields and will use its technology to safely meet growing nationwide demand for lower cost medicines. Jones, currently the VPGM of Medco's Las Vegas Prescription Dispensing Pharmacy, is a seasoned veteran with more than 20 years of Medco pharmacy experience.

"To be part of the dev
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
2. Medco to Webcast Annual Analyst Day Conference
3. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
4. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
5. Protherics UK Ltd. Chooses TrackWise for Corrective Action and Preventive Action (CAPA) Management
6. Notal Vision chooses TrialStats ClinicalAnalytics 4.0 for age-related macular degeneration (AMD) device trial
7. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
8. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
9. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
10. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
11. Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...Nov. 5 SpineSmith Partners has sig...-develop a unique scaffold that mimics the structu...on of several commercial products by SpineSmith,s ...elieves the GenOsteo scaffold represents a signifi...ue and ideal environment for the delivery of adult...
(Date:11/5/2009)... LASIK Surgery and vision correction experts l... actively involved at the recently concluded Ameri...ting in San Francisco, California. Dr. Stephen Bri...n Davidorf, MD, Dr. Peter Rapoza, MD, Dr. Michael ...Bowman, MD, Dr. Edward Manche, MD, and Dr. Parag M...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must be sto...feature film "A Call to Arms:2009 Edition&quo...atal Immunity: The Human Anthrax Vaccine Story&quo...t danger of top secret government science turned i...untability to its victims. It is available for wo...
(Date:11/4/2009)...ILLE, Md., Nov. 4 Zyngenia, Inc., ...n next-generation antibody drug development, today...es A funding from New Enterprise Associates (NEA),... The capital will be used to create novel, multi-s...r more biological targets with a single agent. The...
Breaking Biology Technology:SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
... PAREXEL International,Corporation (Nasdaq: PRXL ...anization, today announced the successful completi...tional Clinical Research Co., Ltd. ("APEX") in,a s...uisition and other,factors discussed herein, the C...uidance for the first quarter of Fiscal Year 2008 ...
... Sept. 26 InterMune, Inc.,(Nasdaq: ITMN ) today ...025,000 shares of common stock at a price to the p...s of common stock, representing the exercise,by th...nal shares in the,offering. The net proceeds to th...million, after payment of underwriting discounts a...
...., Sept. 26 Corium International,Inc., a privatel...nounced,that it has completed a $25.1 million Seri...res. Quantum Technology Partners, Aphelion Capital... round. In connection with,the financing, StrataGe...Ventures portfolio company focused on needle-free ...
Other Biology Technology:PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 2PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 3PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 4InterMune Announces Closing of Public Offering of Common Stock 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 3Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 4
(Date:11/6/2009)... Center and the Chinese Academy of Sciences (CAS) ...on Taste and Smell Research. Organized by Monell i...the first international meeting on taste and smell...utive Officer, American Association for the Advanc...e magazine, will open the meeting with a plenary a...
(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...
(Date:11/4/2009)...ant to officially endorse green tea as a cancer pr...its protective effects, including results of a new...a journal of the American Association for Cancer R...cer. , Vassiliki Papadimitrakopoulo, M.D., prof...ad and Neck Medical Oncology at the University of ...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2UNC scientists garner new NIH awards for high risk transformative research 10076 1UNC scientists garner new NIH awards for high risk transformative research 10076 2UNC scientists garner new NIH awards for high risk transformative research 10076 3UNC scientists garner new NIH awards for high risk transformative research 10076 4Thomson Reuters Predicts Nobel Laureates 14245 1Thomson Reuters Predicts Nobel Laureates 14245 2Thomson Reuters Predicts Nobel Laureates 14245 3Thomson Reuters Predicts Nobel Laureates 14245 4Thomson Reuters Predicts Nobel Laureates 14245 5Thomson Reuters Predicts Nobel Laureates 14245 6RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 1RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 2
.... A hypertension medication called olmesartan med...the arteries that occurs in patients with high blo... Ferrario, M.D., one of the study,s lead investiga... Research Center at Wake Forest University Baptist... the growing evidence for the role of angiotensin ...
...he Smithsonian,s National Zoo have performed the f...s horse ( E. ferus przewalskii ; E. caballus prze...-VAL-skeez. Przewalksi,s horses are a horse specie...xtinct in the wild in 1970. Currently, there are a...oological institutions throughout the world and in...
...nce and technology policymaking capacity of the Wh...ent can better address key issues facing the natio...rity, and the ability of the United States to comp...primary recommendations are that: , The next P...ader to be Assistant for Science and Technology Po...
Other Biology News:Hypertension treatment effective in reversing vascular damage 2First successful reverse vasectomy on endangered species performed at the National Zoo 2First successful reverse vasectomy on endangered species performed at the National Zoo 3White House science office needs upgrade 2White House science office needs upgrade 3
Human SLPI ELISA Kit from R&D Systems
Rabbit Anti-Human OLFM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
GELase 50X Reaction Buffer from EPICENTRE Biotechnologies
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: